Effect of agalsidase alfa replacement therapy on Fabry disease-related hypertrophic cardiomyopathy: a 12- to 36-month, retrospective, blinded echocardiographic pooled analysis (Q44425205)
Jump to navigation
Jump to search
scientific article published in September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of agalsidase alfa replacement therapy on Fabry disease-related hypertrophic cardiomyopathy: a 12- to 36-month, retrospective, blinded echocardiographic pooled analysis |
scientific article published in September 2009 |
Statements
1 reference
Effect of agalsidase alfa replacement therapy on Fabry disease-related hypertrophic cardiomyopathy: a 12- to 36-month, retrospective, blinded echocardiographic pooled analysis (English)
1 reference
1 reference
Richard B Devereux
1 reference
Christoph Kampmann
1 reference
Raphael Schiffmann
1 reference
1 September 2009
1 reference
1 reference
Identifiers
1 reference